Moreover, the tumor microenvironment of CML cells is immune-inhibitory, characterized by an increase in the number of immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) or upregulation of programmed death-1 (PD-1) on CD4/CD8 T cells (Figure 2) [30,31,32]. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.